The latest from MDFA
Potential new treatment for dry AMD
Apellis announces initial results from two phase III studies in geographic atrophy.
AMD: Classification, AREDS, management
This CPD webinar for optometrists will examine the classification of AMD, results and relevance of the AREDS studies, and current referral guidelines and their implications for clinical practice.
Vision Voice spring 2021 out now
The Spring 2021 Vision Voice leads with the Health Minister Greg Hunt, seeking to allay your concerns around Medicare rebate changes.
MBS eye injection: update
MDFA continues to advocate against a proposal to cut Medicare rebates for eye injections and met with the Health Minister in June 2021.
Don’t defer essential eye appointments during lockdown
Macular Disease Foundation Australia (MDFA) is seeking to clear up any confusion around deferring eye appointments during lockdown.
James Muecke MDFA ambassador
Macular Disease Foundation Australia is delighted to officially welcome Dr James Muecke AM on board as MDFA’s diabetic eye disease Ambassador.
With Governments around Australia rolling out vaccines for COVID-19, a frequent question to our National Helpline is about safety of the vaccine when receiving eye injections.
Support life-changing research
Your donations make MDFA the largest non-government source of macular disease research funding in Australia. Donate to our tax appeal to help support life-changing research.
Macular Disease Foundation Australia awards $1 million to eight exciting research projects
Macular Disease Foundation Australia (MDFA) has awarded more than $1 million in research funding to eight promising projects, in a ceremony marking 10 years of significant advances in the search for a cure to Australia’s leading cause of blindness.